• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2023 Fiscal Year Final Research Report

Different roles of C/EBP-alpha in chromosome conformation during lung injury of young and old mice

Research Project

  • PDF
Project/Area Number 21K16142
Research Category

Grant-in-Aid for Early-Career Scientists

Allocation TypeMulti-year Fund
Review Section Basic Section 53030:Respiratory medicine-related
Research InstitutionKanazawa University (2023)
Kyoto University (2021)

Principal Investigator

Gothwal Santosh Kumar  金沢大学, 新学術創成研究機構, 特任助教 (80870526)

Project Period (FY) 2021-04-01 – 2024-03-31
KeywordsC/EBP-alpha / CXCL13 / Super-enhancer / p53 / CXCR5
Outline of Final Research Achievements

As per the cancer genome atlas, the C/EBP-alpha in amplified and over expressed in many cancers. Hydroxyurea (HU) treatment of lung adenocarcinoma A549 cells exhibited C/EBP-alpha's role in promoting the cell viability, suggesting the role of C/EBP-alpha in chemotherapeutic resistance. Ongoing RNA-sequencing of HU-treated 293T cells aims to identify C/EBP-alpha induced genes vital for cell survival. This will allow identifying novel therapeutic targets for treatment of C/EBP-alpha overexpressing cancers. A parallel investigation also uncovered a super enhancer region driving aberrant CXCL13 expression in human cancers. The autocrine signaling in CXCR5-CXCL13 amplified cancers can lead to chemotherapeutic resistance. Several p53 target genes were down regulated by CXCR5-CXCL13 axis in human cancer cells of B-lymphoma origin, Colorectal cancer origin and liver cancer origin. This research identified CXCR5-CXCL13 axis as a new target to overcome the chemotherapeutic resistance in cancer.

Free Research Field

Epigenetics, Chromosome Conformation

Academic Significance and Societal Importance of the Research Achievements

This study explores the role of C/EBP-alpha in cell survival, chemotherapeutic resistance under the DNA-replication stress. The study also explores the mechanism underlying aberrant CXCL13 expression in human cancers. Both findings offer insights into therapeutic avenues for combating human cancers.

URL: 

Published: 2025-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi